SAB Biotherapeutics Inc

Stock Chart, Company Information, and Scan Results

$3.88(as of Jun 15, 3:58 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

SAB Biotherapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$3.88
Ticker SymbolSABS
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees86
CountyUSA
Market Cap$254.6M

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

SAB Biotherapeutics Inc In Our Stock Scanner

As of Jun 16, 2026
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.